Structure

Physi-Chem Properties

Molecular Weight:  295.12
Volume:  298.651
LogP:  2.19
LogD:  2.516
LogS:  -3.087
# Rotatable Bonds:  0
TPSA:  41.93
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.811
Synthetic Accessibility Score:  3.474
Fsp3:  0.333
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.694
MDCK Permeability:  3.352709245518781e-05
Pgp-inhibitor:  0.083
Pgp-substrate:  0.857
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.038

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.992
Plasma Protein Binding (PPB):  86.83987426757812%
Volume Distribution (VD):  3.074
Pgp-substrate:  6.58202600479126%

ADMET: Metabolism

CYP1A2-inhibitor:  0.9
CYP1A2-substrate:  0.807
CYP2C19-inhibitor:  0.36
CYP2C19-substrate:  0.921
CYP2C9-inhibitor:  0.046
CYP2C9-substrate:  0.65
CYP2D6-inhibitor:  0.953
CYP2D6-substrate:  0.904
CYP3A4-inhibitor:  0.668
CYP3A4-substrate:  0.817

ADMET: Excretion

Clearance (CL):  16.038
Half-life (T1/2):  0.093

ADMET: Toxicity

hERG Blockers:  0.162
Human Hepatotoxicity (H-HT):  0.199
Drug-inuced Liver Injury (DILI):  0.129
AMES Toxicity:  0.908
Rat Oral Acute Toxicity:  0.612
Maximum Recommended Daily Dose:  0.888
Skin Sensitization:  0.166
Carcinogencity:  0.629
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.839

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC126284

Natural Product ID:  NPC126284
Common Name*:   Oliveroline
IUPAC Name:   n.a.
Synonyms:   Oliveroline
Standard InCHIKey:  NVMGTUCOAQKLLO-IRXDYDNUSA-N
Standard InCHI:  InChI=1S/C18H17NO3/c1-19-7-6-10-8-13-18(22-9-21-13)15-11-4-2-3-5-12(11)17(20)16(19)14(10)15/h2-5,8,16-17,20H,6-7,9H2,1H3/t16-,17-/m0/s1
SMILES:  CN1CCc2c3[C@H]1[C@@H](O)c1ccccc1c3c1c(c2)OCO1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL221034
PubChem CID:   12444634
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0000381] Aporphines
        • [CHEMONTID:0003021] Hydroxy-7-aporphines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4501 Caragana intermedia Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[15620236]
NPO17687 Duguetia odorata Species Annonaceae Eukaryota n.a. n.a. n.a. PMID[17315964]
NPO24342 Lupinus albus Species Fabaceae Eukaryota Seed n.a. n.a. Database[FooDB]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. Database[FooDB]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO16473 Araucaria bidwillii Species Araucariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24561 Sesuvium portulacastrum Species Aizoaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25009 Cystoseira myrica Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4501 Caragana intermedia Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24939 Veronica officinalis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13718 Poria tenuis Species Coccinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12599.1 Pinus leiophylla var. chihuahuana Varieties Pinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24123 Ramalina scopulorum Species Ramalinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14893 Streptomyces eurocidicus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO28729 Spirostachys africana Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17687 Duguetia odorata Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24723 Ophiorrhiza bracteata Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24342 Lupinus albus Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO23170 Orobanche coerulescens Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO21816 Calea jamaicensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25164 Polyalthia suaveolens Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24593 Campanula pyramidalis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Activity = 35.0 % PMID[529966]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 45000.0 nM PMID[529966]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 20000.0 nM PMID[529966]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC126284 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9878 High Similarity NPC248642
0.9818 High Similarity NPC156576
0.9583 High Similarity NPC214116
0.9521 High Similarity NPC476575
0.9387 High Similarity NPC298979
0.9383 High Similarity NPC225774
0.9341 High Similarity NPC320223
0.9341 High Similarity NPC114364
0.9337 High Similarity NPC128560
0.9337 High Similarity NPC229166
0.9337 High Similarity NPC199465
0.9325 High Similarity NPC476432
0.9325 High Similarity NPC219341
0.9325 High Similarity NPC24264
0.9286 High Similarity NPC267408
0.9268 High Similarity NPC247389
0.9264 High Similarity NPC302527
0.9264 High Similarity NPC16805
0.9264 High Similarity NPC167546
0.9249 High Similarity NPC117717
0.9226 High Similarity NPC148693
0.9226 High Similarity NPC118633
0.9226 High Similarity NPC294790
0.9198 High Similarity NPC160298
0.9198 High Similarity NPC232924
0.9198 High Similarity NPC266753
0.9198 High Similarity NPC306902
0.9198 High Similarity NPC477559
0.9162 High Similarity NPC2314
0.9152 High Similarity NPC210918
0.9107 High Similarity NPC477558
0.9075 High Similarity NPC237579
0.9064 High Similarity NPC116284
0.9064 High Similarity NPC233718
0.9036 High Similarity NPC150879
0.9012 High Similarity NPC135772
0.9006 High Similarity NPC476574
0.9006 High Similarity NPC477561
0.9006 High Similarity NPC312918
0.9006 High Similarity NPC155442
0.8988 High Similarity NPC149090
0.8988 High Similarity NPC19520
0.8929 High Similarity NPC6152
0.8929 High Similarity NPC152212
0.8922 High Similarity NPC12053
0.8922 High Similarity NPC306555
0.8922 High Similarity NPC158376
0.8922 High Similarity NPC117188
0.8922 High Similarity NPC145832
0.8922 High Similarity NPC205421
0.8922 High Similarity NPC81218
0.8922 High Similarity NPC474931
0.8916 High Similarity NPC78222
0.8916 High Similarity NPC13504
0.8916 High Similarity NPC253043
0.8916 High Similarity NPC136508
0.8916 High Similarity NPC477563
0.8916 High Similarity NPC212794
0.8916 High Similarity NPC196447
0.8916 High Similarity NPC96603
0.8916 High Similarity NPC306843
0.8869 High Similarity NPC241055
0.8862 High Similarity NPC86144
0.8862 High Similarity NPC304659
0.8855 High Similarity NPC1229
0.8855 High Similarity NPC233650
0.8855 High Similarity NPC324144
0.8848 High Similarity NPC27410
0.8848 High Similarity NPC166014
0.8844 High Similarity NPC275132
0.8841 High Similarity NPC476572
0.8834 High Similarity NPC325871
0.8834 High Similarity NPC99659
0.8807 High Similarity NPC82763
0.8802 High Similarity NPC134858
0.8802 High Similarity NPC168409
0.88 High Similarity NPC57036
0.8765 High Similarity NPC81733
0.8765 High Similarity NPC326316
0.8757 High Similarity NPC475754
0.875 High Similarity NPC476576
0.875 High Similarity NPC186546
0.8743 High Similarity NPC189470
0.8728 High Similarity NPC220961
0.8721 High Similarity NPC112575
0.8706 High Similarity NPC168753
0.8706 High Similarity NPC118274
0.8698 High Similarity NPC210140
0.869 High Similarity NPC169743
0.8678 High Similarity NPC474506
0.8678 High Similarity NPC32413
0.8671 High Similarity NPC23219
0.8655 High Similarity NPC225597
0.8655 High Similarity NPC470739
0.8655 High Similarity NPC477640
0.8655 High Similarity NPC239775
0.8647 High Similarity NPC82533
0.8647 High Similarity NPC290759
0.8647 High Similarity NPC266176
0.8647 High Similarity NPC475686
0.8647 High Similarity NPC158148
0.8647 High Similarity NPC58766
0.8631 High Similarity NPC320104
0.8621 High Similarity NPC470879
0.8621 High Similarity NPC258695
0.8605 High Similarity NPC477020
0.8605 High Similarity NPC66341
0.8605 High Similarity NPC192135
0.8596 High Similarity NPC69712
0.8596 High Similarity NPC474475
0.8596 High Similarity NPC477562
0.8596 High Similarity NPC26240
0.8588 High Similarity NPC190332
0.8588 High Similarity NPC181653
0.858 High Similarity NPC276944
0.858 High Similarity NPC232514
0.858 High Similarity NPC238530
0.8555 High Similarity NPC187678
0.8539 High Similarity NPC474904
0.8529 High Similarity NPC35627
0.8529 High Similarity NPC81247
0.8529 High Similarity NPC476573
0.8514 High Similarity NPC244554
0.8494 Intermediate Similarity NPC244112
0.8494 Intermediate Similarity NPC41178
0.8494 Intermediate Similarity NPC216459
0.8494 Intermediate Similarity NPC138487
0.8488 Intermediate Similarity NPC311991
0.848 Intermediate Similarity NPC100566
0.8466 Intermediate Similarity NPC475959
0.8462 Intermediate Similarity NPC60186
0.8452 Intermediate Similarity NPC111485
0.8452 Intermediate Similarity NPC477080
0.8443 Intermediate Similarity NPC126519
0.8443 Intermediate Similarity NPC146288
0.8443 Intermediate Similarity NPC203784
0.8443 Intermediate Similarity NPC170503
0.8421 Intermediate Similarity NPC124657
0.8409 Intermediate Similarity NPC474507
0.8402 Intermediate Similarity NPC249274
0.8402 Intermediate Similarity NPC97072
0.8402 Intermediate Similarity NPC215829
0.84 Intermediate Similarity NPC476577
0.84 Intermediate Similarity NPC474470
0.84 Intermediate Similarity NPC173416
0.84 Intermediate Similarity NPC237044
0.84 Intermediate Similarity NPC241704
0.84 Intermediate Similarity NPC148709
0.8383 Intermediate Similarity NPC76079
0.8373 Intermediate Similarity NPC26601
0.8352 Intermediate Similarity NPC474325
0.8343 Intermediate Similarity NPC59028
0.8343 Intermediate Similarity NPC304675
0.8343 Intermediate Similarity NPC92191
0.8333 Intermediate Similarity NPC312531
0.8333 Intermediate Similarity NPC323443
0.8333 Intermediate Similarity NPC180756
0.8333 Intermediate Similarity NPC234392
0.8333 Intermediate Similarity NPC31311
0.8306 Intermediate Similarity NPC162653
0.8305 Intermediate Similarity NPC474745
0.8305 Intermediate Similarity NPC32154
0.8303 Intermediate Similarity NPC219162
0.8303 Intermediate Similarity NPC211296
0.8294 Intermediate Similarity NPC4304
0.8294 Intermediate Similarity NPC205167
0.8293 Intermediate Similarity NPC476151
0.8282 Intermediate Similarity NPC185838
0.8276 Intermediate Similarity NPC329911
0.8266 Intermediate Similarity NPC204947
0.8263 Intermediate Similarity NPC210148
0.8263 Intermediate Similarity NPC233029
0.8258 Intermediate Similarity NPC179704
0.8256 Intermediate Similarity NPC247972
0.8249 Intermediate Similarity NPC15919
0.8225 Intermediate Similarity NPC186063
0.8222 Intermediate Similarity NPC9867
0.8218 Intermediate Similarity NPC160570
0.8212 Intermediate Similarity NPC249405
0.8208 Intermediate Similarity NPC476002
0.8202 Intermediate Similarity NPC99179
0.8197 Intermediate Similarity NPC78284
0.8193 Intermediate Similarity NPC103379
0.8193 Intermediate Similarity NPC477565
0.8192 Intermediate Similarity NPC287588
0.8182 Intermediate Similarity NPC253883
0.8182 Intermediate Similarity NPC90844
0.8182 Intermediate Similarity NPC95075
0.8182 Intermediate Similarity NPC321505
0.8182 Intermediate Similarity NPC179825
0.8182 Intermediate Similarity NPC191376
0.8171 Intermediate Similarity NPC75958
0.8171 Intermediate Similarity NPC145304
0.8167 Intermediate Similarity NPC474746
0.8167 Intermediate Similarity NPC475981
0.8166 Intermediate Similarity NPC93593
0.8166 Intermediate Similarity NPC204828
0.8166 Intermediate Similarity NPC5238
0.8166 Intermediate Similarity NPC249797
0.8166 Intermediate Similarity NPC78733

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC126284 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8639 High Similarity NPD3051 Approved
0.8588 High Similarity NPD2969 Approved
0.8588 High Similarity NPD2970 Approved
0.843 Intermediate Similarity NPD2489 Approved
0.843 Intermediate Similarity NPD27 Approved
0.838 Intermediate Similarity NPD7906 Approved
0.8362 Intermediate Similarity NPD4578 Approved
0.8362 Intermediate Similarity NPD4577 Approved
0.8333 Intermediate Similarity NPD5241 Discontinued
0.8333 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD4663 Approved
0.8121 Intermediate Similarity NPD2420 Approved
0.8121 Intermediate Similarity NPD2421 Approved
0.8114 Intermediate Similarity NPD4481 Phase 3
0.8072 Intermediate Similarity NPD4584 Approved
0.8061 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6071 Discontinued
0.7989 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD2563 Approved
0.7965 Intermediate Similarity NPD2560 Approved
0.7956 Intermediate Similarity NPD7310 Approved
0.7956 Intermediate Similarity NPD7313 Approved
0.7956 Intermediate Similarity NPD7312 Approved
0.7956 Intermediate Similarity NPD7311 Approved
0.7912 Intermediate Similarity NPD7309 Approved
0.7907 Intermediate Similarity NPD2977 Approved
0.7907 Intermediate Similarity NPD2978 Approved
0.7892 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD2973 Approved
0.7872 Intermediate Similarity NPD2975 Approved
0.7872 Intermediate Similarity NPD2974 Approved
0.7801 Intermediate Similarity NPD2494 Approved
0.7801 Intermediate Similarity NPD3450 Approved
0.7801 Intermediate Similarity NPD3452 Approved
0.7801 Intermediate Similarity NPD2493 Approved
0.7796 Intermediate Similarity NPD2490 Approved
0.7796 Intermediate Similarity NPD2488 Approved
0.7791 Intermediate Similarity NPD4772 Phase 2
0.7791 Intermediate Similarity NPD4773 Phase 2
0.7771 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7831 Phase 2
0.7771 Intermediate Similarity NPD7833 Phase 2
0.776 Intermediate Similarity NPD2971 Approved
0.776 Intermediate Similarity NPD2968 Approved
0.7749 Intermediate Similarity NPD4580 Approved
0.7737 Intermediate Similarity NPD4420 Approved
0.7717 Intermediate Similarity NPD8054 Approved
0.7717 Intermediate Similarity NPD8053 Approved
0.7709 Intermediate Similarity NPD2898 Approved
0.768 Intermediate Similarity NPD4582 Approved
0.768 Intermediate Similarity NPD4583 Approved
0.768 Intermediate Similarity NPD8156 Discontinued
0.7665 Intermediate Similarity NPD4237 Approved
0.7665 Intermediate Similarity NPD4236 Phase 3
0.7632 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD4004 Approved
0.7629 Intermediate Similarity NPD4002 Approved
0.7624 Intermediate Similarity NPD8251 Approved
0.7624 Intermediate Similarity NPD8099 Discontinued
0.7624 Intermediate Similarity NPD8252 Approved
0.7614 Intermediate Similarity NPD6788 Approved
0.7614 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7577 Intermediate Similarity NPD5005 Approved
0.7577 Intermediate Similarity NPD5006 Approved
0.7572 Intermediate Similarity NPD4017 Approved
0.7544 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD1753 Discontinued
0.75 Intermediate Similarity NPD7243 Clinical (unspecified phase)
0.7475 Intermediate Similarity NPD7047 Phase 3
0.7472 Intermediate Similarity NPD5604 Discontinued
0.7457 Intermediate Similarity NPD4727 Phase 1
0.7456 Intermediate Similarity NPD5177 Phase 3
0.7456 Intermediate Similarity NPD3060 Approved
0.7448 Intermediate Similarity NPD5582 Discontinued
0.7443 Intermediate Similarity NPD7298 Approved
0.743 Intermediate Similarity NPD7400 Phase 3
0.7427 Intermediate Similarity NPD6997 Phase 2
0.7427 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD3845 Phase 1
0.7425 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4010 Discontinued
0.7398 Intermediate Similarity NPD3057 Approved
0.7394 Intermediate Similarity NPD3109 Approved
0.7394 Intermediate Similarity NPD3110 Approved
0.7391 Intermediate Similarity NPD6042 Phase 2
0.7391 Intermediate Similarity NPD42 Phase 2
0.7356 Intermediate Similarity NPD3640 Phase 3
0.7356 Intermediate Similarity NPD6030 Approved
0.7356 Intermediate Similarity NPD5976 Discontinued
0.7356 Intermediate Similarity NPD3641 Approved
0.7356 Intermediate Similarity NPD3639 Approved
0.7356 Intermediate Similarity NPD6031 Approved
0.7337 Intermediate Similarity NPD4721 Approved
0.7337 Intermediate Similarity NPD4725 Approved
0.7337 Intermediate Similarity NPD4726 Approved
0.7333 Intermediate Similarity NPD5709 Phase 3
0.7327 Intermediate Similarity NPD7827 Phase 1
0.7312 Intermediate Similarity NPD6297 Approved
0.731 Intermediate Similarity NPD3533 Approved
0.731 Intermediate Similarity NPD2972 Approved
0.7303 Intermediate Similarity NPD5773 Approved
0.7303 Intermediate Similarity NPD5772 Approved
0.7293 Intermediate Similarity NPD4666 Phase 3
0.7287 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5160 Discontinued
0.7253 Intermediate Similarity NPD6107 Approved
0.7249 Intermediate Similarity NPD6853 Approved
0.7249 Intermediate Similarity NPD6851 Approved
0.7249 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD4040 Phase 1
0.7234 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6666 Approved
0.7225 Intermediate Similarity NPD6667 Approved
0.7222 Intermediate Similarity NPD2491 Approved
0.7222 Intermediate Similarity NPD3448 Approved
0.7212 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD5754 Discontinued
0.72 Intermediate Similarity NPD6090 Discontinued
0.7196 Intermediate Similarity NPD7280 Phase 3
0.7196 Intermediate Similarity NPD7281 Phase 3
0.7193 Intermediate Similarity NPD7037 Approved
0.7192 Intermediate Similarity NPD5676 Approved
0.7189 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD4055 Discovery
0.7175 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD4005 Discontinued
0.7169 Intermediate Similarity NPD5718 Phase 2
0.7157 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4123 Phase 3
0.7126 Intermediate Similarity NPD4475 Approved
0.7126 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD4474 Approved
0.7121 Intermediate Similarity NPD4107 Approved
0.7108 Intermediate Similarity NPD5155 Approved
0.7108 Intermediate Similarity NPD5156 Approved
0.7101 Intermediate Similarity NPD4579 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD5938 Phase 3
0.7083 Intermediate Similarity NPD2238 Phase 2
0.7079 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD7262 Phase 1
0.7069 Intermediate Similarity NPD3692 Discontinued
0.7065 Intermediate Similarity NPD7802 Discontinued
0.7062 Intermediate Similarity NPD1914 Approved
0.7062 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD6674 Discontinued
0.7052 Intermediate Similarity NPD4162 Approved
0.7048 Intermediate Similarity NPD2605 Approved
0.7048 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD2606 Approved
0.7048 Intermediate Similarity NPD3595 Approved
0.7048 Intermediate Similarity NPD7907 Approved
0.7048 Intermediate Similarity NPD3594 Approved
0.7045 Intermediate Similarity NPD1424 Approved
0.7035 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD4665 Approved
0.7033 Intermediate Similarity NPD4111 Phase 1
0.7027 Intermediate Similarity NPD4166 Phase 2
0.7022 Intermediate Similarity NPD4210 Discontinued
0.7018 Intermediate Similarity NPD4108 Discontinued
0.7011 Intermediate Similarity NPD6331 Phase 2
0.7011 Intermediate Similarity NPD6037 Discontinued
0.701 Intermediate Similarity NPD7235 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6072 Discontinued
0.7 Intermediate Similarity NPD4482 Phase 3
0.6989 Remote Similarity NPD7213 Phase 3
0.6989 Remote Similarity NPD7212 Phase 2
0.6989 Remote Similarity NPD6688 Approved
0.6989 Remote Similarity NPD6687 Approved
0.6989 Remote Similarity NPD3124 Discontinued
0.6988 Remote Similarity NPD3637 Approved
0.6988 Remote Similarity NPD3635 Approved
0.6988 Remote Similarity NPD3636 Approved
0.6974 Remote Similarity NPD6656 Clinical (unspecified phase)
0.6974 Remote Similarity NPD3808 Clinical (unspecified phase)
0.6971 Remote Similarity NPD2677 Approved
0.697 Remote Similarity NPD4103 Phase 2
0.697 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6961 Remote Similarity NPD37 Approved
0.6961 Remote Similarity NPD4859 Phase 1
0.6952 Remote Similarity NPD3763 Approved
0.6951 Remote Similarity NPD4659 Approved
0.6949 Remote Similarity NPD7447 Phase 1
0.6949 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6947 Remote Similarity NPD7007 Discovery
0.6944 Remote Similarity NPD4678 Approved
0.6944 Remote Similarity NPD4675 Approved
0.6943 Remote Similarity NPD5087 Clinical (unspecified phase)
0.6936 Remote Similarity NPD1375 Discontinued
0.6936 Remote Similarity NPD2174 Clinical (unspecified phase)
0.6936 Remote Similarity NPD7030 Discontinued
0.6931 Remote Similarity NPD5312 Approved
0.6931 Remote Similarity NPD5095 Phase 3
0.6931 Remote Similarity NPD5096 Phase 3
0.6931 Remote Similarity NPD5313 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data